{"id":44728,"date":"2019-03-25T19:43:06","date_gmt":"2019-03-25T17:43:06","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=44728"},"modified":"2019-03-25T19:43:06","modified_gmt":"2019-03-25T17:43:06","slug":"pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/","title":{"rendered":"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria"},"content":{"rendered":"<p>Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del <strong>Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria<\/strong>, titulada <strong>&#8220;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&#8221;\u00a0<\/strong>adre\u00e7ada als <strong>farmac\u00e8utics<\/strong> de farm\u00e0cia comunit\u00e0ria.<\/p>\n<p>Els ponents van ser <strong>Elena Ad\u00e1n<\/strong>, subdirecci\u00f3 General de Drogodepend\u00e8ncies, Ag\u00e8ncia de Salut P\u00fablica de Catalunya;\u00a0<strong>Pasqual Bala\u00f1\u00e0<\/strong>, farmac\u00e8utic comunitari;\u00a0<strong>Joan Brugueras<\/strong>, farmac\u00e8utic comunitari i coordinador de farm\u00e0cies Vall\u00e8s Occidental;\u00a0<strong>Francisco Garc\u00eda-Vela<\/strong>, farmac\u00e8utic comunitari; <strong>Montserrat Torrens<\/strong>,\u00a0 <strong>Carmina Subirana<\/strong> i <strong>Marco Mocelin.<\/strong> La moderaci\u00f3 de\u00a0l&#8217;acte va anar a c\u00e0rrec de <strong>Guillermo Bagaria<\/strong>, vicetresorer i responsable d&#8217;Atenci\u00f3 Farmac\u00e8utica del COFB.<\/p>\n<figure id=\"attachment_44910\" aria-describedby=\"caption-attachment-44910\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/03\/cofb.190305-26.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-44910 size-large\" title=\"Un moment de la confer\u00e8ncia sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, &quot;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&quot;.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/03\/cofb.190305-26-1024x683.jpg\" alt=\"Un moment de la confer\u00e8ncia sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, &quot;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&quot;.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-44910\" class=\"wp-caption-text\">Un moment de la confer\u00e8ncia sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, &#8220;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&#8221;.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes<\/strong><\/span><\/h1>\n<p>La confer\u00e8ncia es va centrar en la <strong>justificaci\u00f3<\/strong>, el <strong>desplegament<\/strong> i els <strong>objectius<\/strong> del <strong>pla funcional del PIX<\/strong>, aix\u00ed com en la <strong>import\u00e0ncia<\/strong> de la <strong>participaci\u00f3<\/strong> de les <strong>farm\u00e0cies<\/strong> en <strong>estrat\u00e8gies<\/strong> de <strong>reducci\u00f3<\/strong> <strong>de danys<\/strong> a la societat.<\/p>\n<p>De la mateixa manera, es van exposar <strong>casos cl\u00ednics<\/strong>, <strong>experi\u00e8ncies<\/strong>\u00a0personals dels ponents com a farmac\u00e8utics, i la <strong>gesti\u00f3 de conflictes<\/strong> en la prestaci\u00f3 dels serveis professionals per reduir els riscos en la farm\u00e0cia comunit\u00e0ria.<\/p>\n<h2><span style=\"color: #008080;\"><strong>Focus en el PIX<\/strong><\/span><\/h2>\n<p>Durant la xerrada, s&#8217;ha prestat una especial atenci\u00f3 al <strong>Programa d&#8217;intercanvi de xeringues (PIX)<\/strong>,\u00a0els seus\u00a0<strong>objectius<\/strong>, els\u00a0<strong>\u00a0destinataris<\/strong>, els <strong>materials<\/strong> de <strong>dispensaci\u00f3<\/strong>, aix\u00ed com en l&#8217;<strong>evoluci\u00f3 hist\u00f2rica<\/strong> del servei i la <strong>implementaci\u00f3<\/strong> del <strong>pla<\/strong> <strong>funcional<\/strong>. Com destaca Bagaria,<strong> &#8220;<\/strong><strong>les dificultats relacionades amb la gesti\u00f3 de les relacions amb els usuaris ha pivotat gran part de la xerrada&#8221;<\/strong>, tot i que tamb\u00e9 es van <strong>abordar<\/strong> aspectes relacionats amb el <strong>Programa de Manteniment de Metadona<\/strong> o el <strong>VIH<\/strong>&#8220;.<\/p>\n<figure id=\"attachment_44964\" aria-describedby=\"caption-attachment-44964\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/03\/cofb.190305-09.jpg\"><img decoding=\"async\" class=\"wp-image-44964 size-large\" title=\"Guillermo Bagaria, vicetresorer i responsable d'Atenci\u00f3 Farmac\u00e8utica del COFB, va moderar la sessi\u00f3.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/03\/cofb.190305-09-1024x683.jpg\" alt=\"Guillermo Bagaria, vicetresorer i responsable d'Atenci\u00f3 Farmac\u00e8utica del COFB, va moderar la sessi\u00f3.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-44964\" class=\"wp-caption-text\">Guillermo Bagaria, vicetresorer i responsable d&#8217;Atenci\u00f3 Farmac\u00e8utica del COFB, va moderar la sessi\u00f3.<\/figcaption><\/figure>\n<h2><span style=\"color: #008080;\"><strong>Valoraci\u00f3 de la sessi\u00f3<br \/>\n<\/strong><\/span><\/h2>\n<p>El\u00a0<strong>responsable d&#8217;Atenci\u00f3 Farmac\u00e8utica<\/strong> del COFB, Guillermo Bagaria, ha valorat que la sessi\u00f3 &#8220;<strong>ha estat molt interessant<\/strong> perqu\u00e8 <strong>vuit farmac\u00e8utics<\/strong> han pogut compartir i traslladar la seva <strong>experi\u00e8ncia personal, dirigint-se a professionals que encara no havien abordat la prestaci\u00f3 del servei<\/strong>, o b\u00e9 que, havent-lo prestat, tenien <strong>dubtes sobre la seva operativa<\/strong>.&#8221; En definitiva, &#8220;s&#8217;ha fet una explicaci\u00f3 en conjunt amb diferents <strong>testimonis<\/strong> i s&#8217;ha parlat de l&#8217;<strong>abordatge del pacient<\/strong>, de <strong>com atendre&#8217;l,<\/strong>\u00a0de <strong>com gestionar-lo<\/strong> i com <strong>actuar davant les retic\u00e8ncies,<\/strong> tant de la resta d&#8217;usuaris de la farm\u00e0cia, com dels equips de les farm\u00e0cies, per tal de superar-les i de <strong>poder prestar el millor servei de la millor manera<\/strong>&#8220;.<\/p>\n<p>&nbsp;<\/p>\n<div class=\"box success\">\n<h2><span style=\"color: #008080;\"><strong>\u00daltima confer\u00e8ncia del cicle de reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria<\/strong><\/span><\/h2>\n<ul>\n<li><strong>Subst\u00e0ncies d\u2019ab\u00fas: OMA Consum de l\u2019alcohol i drogues a l\u2019adolesc\u00e8ncia. (Data a confirmar pr\u00f2ximament)<\/strong><em><strong>\u00a0<\/strong><\/em><\/div><\/li>\n<\/ul>\n<p><strong>Altres publicacions d&#8217;inter\u00e8s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/opioides-majors-atencio-farmaceutica-pmm-tercera-sessio-cicle-conferencies-sobre-reduccio-riscos-farmacia-comunitaria\/\" target=\"_blank\" rel=\"noopener\">Opioides majors, atenci\u00f3 farmac\u00e8utica i PMM: Tercera sessi\u00f3 del cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria (Febrer 2019)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/pautes-consum-dheroina-cocaina-catalunya-atencio-farmaceutica-contrarestar-danys-cicle-conferencies-sobre-reduccio-riscos-farmacia-comunitaria\/\" target=\"_blank\" rel=\"noopener\">Pautes de consum d\u2019hero\u00efna i coca\u00efna a Catalunya i atenci\u00f3 farmac\u00e8utica per contrarestar els danys [Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria] (Gener 2019)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/us-terapeutic-cannabis-comenca-cicle-conferencies-sobre-reduccio-riscos-farmacia-comunitaria\/\" target=\"_blank\" rel=\"noopener\">\u00das terap\u00e8utic del c\u00e0nnabis. Comen\u00e7a el cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria (Gener 2019)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada &#8220;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&#8221;\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria. Els ponents van ser Elena Ad\u00e1n, subdirecci\u00f3 General de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":44909,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,3461,3373,18,19,53,69,70,2979,3462],"class_list":["post-44728","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-casos-practics-i-gestio-de-conflictes","tag-cicle-de-conferencies-sobre-reduccio-de-riscos-en-la-farmacia-comunitaria","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmacia-comunitaria","tag-formacio","tag-pix","tag-pmm-i-vih-experiencies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada &quot;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&quot;\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada &quot;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&quot;\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-25T17:43:06+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria\",\"datePublished\":\"2019-03-25T17:43:06+00:00\",\"dateModified\":\"2019-03-25T17:43:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\"},\"wordCount\":638,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"casos pr\u00e0ctics i gesti\u00f3 de conflictes\\\"\",\"Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"PIX\",\"PMM i VIH: Experi\u00e8ncies\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\",\"name\":\"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2019-03-25T17:43:06+00:00\",\"dateModified\":\"2019-03-25T17:43:06+00:00\",\"description\":\"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada \\\"PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes\\\"\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada \"PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes\"\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/","og_locale":"ca_ES","og_type":"article","og_title":"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada \"PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes\"\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria.","og_url":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2019-03-25T17:43:06+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria","datePublished":"2019-03-25T17:43:06+00:00","dateModified":"2019-03-25T17:43:06+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/"},"wordCount":638,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","casos pr\u00e0ctics i gesti\u00f3 de conflictes\"","Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","PIX","PMM i VIH: Experi\u00e8ncies"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/","url":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/","name":"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-03-25T17:43:06+00:00","dateModified":"2019-03-25T17:43:06+00:00","description":"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada \"PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes\"\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2019\/03\/25\/pix-pmm-vih-compartint-mes-experiencies-sobre-la-reduccio-de-riscos-en-la-farmacia-comunitaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"PIX, PMM, VIH: Compartint m\u00e9s experi\u00e8ncies sobre la reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Aquest mes de mar\u00e7 es va celebrar al Col\u00b7legi la quarta sessi\u00f3 del Cicle de confer\u00e8ncies sobre reducci\u00f3 de riscos en la farm\u00e0cia comunit\u00e0ria, titulada &#8220;PIX, PMM i VIH: Experi\u00e8ncies, casos pr\u00e0ctics i gesti\u00f3 de conflictes&#8221;\u00a0adre\u00e7ada als farmac\u00e8utics de farm\u00e0cia comunit\u00e0ria. Els ponents van ser Elena Ad\u00e1n, subdirecci\u00f3 General de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/44728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=44728"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/44728\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=44728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=44728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=44728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}